To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic Hypertension

PHASE1TerminatedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Chronic Hypertension
Interventions
DRUG

TC-5214

Tablet oral bid days 1 to 7

DRUG

TC-5214

Tablet oral bid days 8 to 14

Trial Locations (4)

Unknown

Research Site, Overland Park

Research Site, Willingboro

Research Site, Berlin

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY